Navigation Links
Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner
Date:9/11/2007

Recognized for Leadership in Clean Technology and Global Business Potential

SOUTH SAN FRANCISCO, Calif., Sept. 11 /PRNewswire/ -- Solazyme, Inc., a leading algal biotechnology company, today announced that it has been selected by AlwaysOn as one of the GoingGreen 100 Top Private Companies for 2007. The first-annual elite GoingGreen 100 list was compiled by the AlwaysOn editorial panel. In order to be eligible for the GoingGreen 100 list, companies had to be peer-nominated, with AlwaysOn receiving more than 500 nominations from venture investors, investment bankers and other industry experts.

"The AlwaysOn GoingGreen 100 companies will accelerate the global movement to a more sustainable environment," said Tony Perkins, founder and editor of AlwaysOn. "The ideas and innovation we saw as we reviewed hundreds of clean technology companies will be foundational to the next wave of economic growth in California and beyond. My congratulations to each AlwaysOn GoingGreen 100 winner -- these are the companies which we predict will have the greatest market traction, strongest innovation and most game-changing approaches this year."

Solazyme and the GoingGreen 100 Top Private Companies for 2007 will be honored at AlwaysOn GoingGreen to be held at the University of California in Davis from September 10 -- 12. GoingGreen is a two-and-a-half-day executive gathering that highlights the significant impact clean technologies have on new economic growth and in sustainable use of natural resources. The idea behind the GoingGreen 100 top private companies list is to identify the most promising entrepreneurial opportunities and investments in the clean technology industry.

Solazyme is a leading biotechnology company focused on the engineering and optimization of algae for production of biofuels and health and wellness materials. Solazyme has developed algal strains with dramatically increased biofuel and industrial chemical production capabilities. This novel technology results in large reductions in CO2 and other pollutants over traditional fossil fuels.

"We are pleased to be recognized for our development of fuels and industrial chemicals from renewable resources. Our focus on algal biotechnology will enable rapid development and deployment of facilities capable of producing commercial scale quantities of biodiesel," said Jonathan Wolfson, President of Solazyme. Harrison Dillon, CEO of Solazyme, added "The use of renewable resources for production of biofuels that are compatible with the existing transportation fuel infrastructure and that meet existing fuel standards is crucially important for rapid large scale adoption. We are excited to make a major contribution to reducing our dependency on imported oil and creating new employment opportunities for Americans."

A full list of all the AlwaysOn GoingGreen 100 Private Companies can be found on the AlwaysOn Web site at: http://alwayson.goingon.com/permalink/post/18632

About AlwaysOn GoingGreen: AlwaysOn GoingGreen is a two-and-a-half-day executive gathering that highlights the significant impact clean technologies have on new economic growth and in sustainable use of natural resources. AlwaysOn GoingGreen features the most innovative companies, eminent technologists, influential investors and journalists in keynote presentations, panel debates and private company CEO showcases. The goal of the conference is to identify the most promising entrepreneurial opportunities and investments in the clean tech industry.

About Solazyme:

Founded in 2003 and headquartered in South San Francisco, California, Solazyme is a leading biotechnology company focused on the engineering and optimization of algae for production of biofuels and health and wellness materials. For more information, please visit our website: http://www.solazyme.com.

About AlwaysOn

AlwaysOn ignited the open-media revolution in early 2003 by being the first media brand to launch a global blog network. In 2004, AlwaysOn continued to lead the media industry in innovation by introducing a social network where members can connect and engage. AlwaysOn is also revolutionizing the media business by applying its open-media principles to its executive event series (Stanford Summit, AlwaysOn Hollywood, AlwaysOn Media and GoingGreen) and quarterly print "blogozine" by empowering its members to post and share their ideas and meet each other online. As our loyal readers know, AlwaysOn is committed to the free-market, merit-driven approach to reporting and event programming. No other media brand has dared to create such open interaction with its readers and event participants.

For Solazyme For AlwaysOn Going Green

Walter Rakitsky A&R Edelman

Ph: 650-780-4777 Kimberly Kupiecki

wrakitsky@solazyme.com Ph: 650-533-4049

kkupiecki@ar-edelman.com


'/>"/>
SOURCE Solazyme, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. San Diego firm selected for Madison Wi-Fi project
2. Milwaukee-based eFilm software selected by InSight Health, announces Workstation upgrade
3. Berbee Selected by Microsoft as Featured Speaker for New Product Launch
4. In pursuit of capital, be sure to track your private offering
5. When raising capital, why use a Private Placement Memorandum?
6. Of private equity, research, and drug development
7. Third Wave Technologies to raise $14.9M through private debt
8. Computer recycling: An environmental mandate the private sector can support
9. With patents and research tools, when is private really public?
10. Platypus raises $1.2 million from private investors
11. Wisconsin private college group picks Jenzabar for common IT platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology:
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
Breaking Biology News(10 mins):